Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo

Carcinogenesis

Volumn 19, Issue 6, 1998, Pages 1013-1018

  Wei, Huachen ^a   Cai, Qiuyin ^b   Tian, Liqun ^b   Lebwohl, Mark ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CARBONYL DERIVATIVE; DNA; GLUTATHIONE; LIPID; MALONALDEHYDE; PROTEIN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; EPIDERMIS; FEMALE; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RADIATION CARCINOGENESIS; SKIN CARCINOGENESIS; THYMUS; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET IRRADIATION;

ANIMALS; CATTLE; DEOXYGUANOSINE; DNA; DNA DAMAGE; FEMALE; MICE; MICE, INBRED HRS; OXIDATIVE STRESS; SKIN; TAMOXIFEN; ULTRAVIOLET RAYS;

EID: 0031903505     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.6.1013     Document Type: Article

References (39)

1. Ribeiro,G. and Swindell,R. (1988) The Christie hospital adjuvant tamoxifen trial - status at 10 years. J. Cancer, 57, 601-603.
2. Lerner,L.J. and Jordan,V.C. (1990) Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture. Cancer Res., 50, 4177-4189.
3. Love,RR. (1993) The National Surgical Adjuvant Breast Project (NSABP) breast cancer prevention trial revisited. Cancer Epidemiol., Biomarkers Prev., 2, 403-407.
4. Bush,T.L. and Helzlsouer,K.J. (1993) Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. Epidemiol. Rev., 15, 233-243.
5. Jordan,V.C. (1995) Tamoxifen for breast cancer prevention. Proc. Soc. Exp. Biol. Med., 208, 144-149.
6. Farinati,F., Demaria,N., Fornasier,A., Salvangini,M., Fagiuoli,S., Chiaramonte,M. and Naccarto,R. (1992) Prospective controlled trial with the antioestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Digestive Dis. Sci., 37, 659-662.
7. Couldwell,W.T., Weiss,M.H., Degiorgio,C.M., Weiner,L.P., Hinton,D.R., Ehresmsan,G.R., Conti,P.S., Apuzzo,M.L.J., Kornblith,P. and Detriboler,N. (1993) Clinical and radiographic response in patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery, 32, 485-490.
8. Taylor,O.M., Benson,E.A. and McMahon,M.J. (1993) Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. Br. J. Surg., 80, 384-386.
9. Wiseman,H., Laughton,M.J., Arnstein,H.R.V., Cannon,M. and Halliwell,B. (1990) The anti-oxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation. FEBS Lett., 263, 192-194.
10. Wiseman, H. (1994) The anti-oxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17-oestradiol and relevance to its anticancer potential. Biochem. Pharmacol., 47, 493-498.
11. Wiseman,H. and Halliwell,B. (1994) Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen? Free Rad. Biol. Med., 17, 485-488.
12. Cust'dio,J.B.A., Dinis,T.C.P., Almedia,L.M. and Madeira,V.M.C. (1994) Tamoxifen and hydroxytamoxifen as intramembranous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem. Pharmacol., 47, 1989-1998.
13. Thangaraju,M., Vijayalakshmi,T. and Sachdanandam,P. (1992) Effect of tamoxifen on lipid peroxide and antioxidative enzyme in postmenopausal women with breast cancer. Cancer, 74, 78-82.
14. Lim,J.S., Frenkel,K. and Troll,W. (1992) Tamoxifen suppresses tumor promoter-induced hydrogen peroxide formation by human neutrophils. Cancer Res., 52, 4969-4972.
15. Bhimani,R., Troll,W., Grunberger,D. and Frenkel,K. (1993) Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res., 53, 4528-4533.
16. Wei,H. and Frenkel,K. (1993) Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis, 14, 1195-1201.
17. Frenkel,K. (1992) Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther., 53, 127-166.
18. Shigenaga,M.K., Gimeno,C.-J. and Ames,B.N. (1989) Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl Acad. Sci. USA, 86, 9697-9701.
19. Floyd,R.A. (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis, 11, 1447-1450.
20. Fischer-Nielsen,A., Poulsen,H.E. and Loft,S. (1992) 8-Hydroxy-deoxyguanosine in vitro: effect of glutathione, ascorbate, and 5-aminosalicylic acid. Free Rad. Biol. Med., 13, 121-126.
21. Floyd,R.A., Watson,J.J., Wong,P.K., Altmiller,D.H. and Rickard,R.C. Hydroxyl free radical adduct of deoxyguanosine: Sensitive detection and mechanisms of formation. Free Rad. Res. Commun., 1, 163-172.
22. Wei,H., Cai,Q. and Rahn,R. (1996) Inhibition of UV light-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis, 17, 73-77.
23. Wei,H., Cai,Q., Rahn,R. and Zhang,X. (1997) Singlet oxygen involvement in ultraviolet (254 nm) radiation-induced formation of 8-hydroxydeoxyguanosine in DNA. Free Rad. Biol. Med., 23, 148-154.
24. Zhang,X., Rosenstein,B.S., Wang,Y., Lebwohl,M., Mitchell,D. and Wei,H. (1997) Induction of 8-hydroxy-2′-deoxyguanosine by UV radiation in calf thymus DNA and Hela cells. Photochem. Photobiol., 65, 119-124.
25. Hattori,N., Nishigori,C., Tanaka,T., Uchida,K., Nikaido,O., Osawa,T., Hiai,H., Imamura,S. and Toyokuni,S. (1996) 8-hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J. Invest. Dermatol., 107, 733-737.
26. Hattori-Nakakuki,Y., Nishigori,C., Okamoto,K., Imamura,S., Hiai,H. and Toyokuni,S. (1994) Formation of 8-hydroxy-2′-deoxyguanosine in epidermis of hairless mice exposed to near-UV. Biochem. Biophys. Res. Commun., 201, 1132-1139.
27. Ohkawa,H., Ohishi,N. and Yagi,K. (1979) Assay for lipid peroxides in animal tissue by thioharbituric acid reaction. Anal. Biochem., 95, 351-358.
28. Levine,R.L., Garland,D., Oliver,C.N., Amici,A., Climent,I., Lenz,A.-G., Ahn,B.-W., Shaltiel,S. and Stadtman,E.R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol., 186, 464-478.
29. Lewis, J.G. and Adams,D.O. (1986) Enhanced release of hydrogen peroxide and metabolites of urachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters. Cancer Res., 46, 5696-5700.
30. Wei, L., Wei, H., and Frenkel, K. (1993) Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage. Carcinogenesis, 14, 841-847.
31. Epe,B. (1991) Genotoxicity of singlet oxygen. Chem. Biol. Interactions, 80, 239-260.
32. Piette, J. (1991) Biological consequences associated with DNA oxidation mediated by singlet oxygen. J. Photochem. Photobiol., 11, 241-260.
33. Swenberg,J.A. (1997) Clinical relevance of laboratory and animal data on tamoxifen. Oncology, 11 (Suppl. 1), 39-44.
34. Wogan,G.N. Review of the toxicology of tamoxifen. Semin Oncol., 24 (Suppl. 1), S1-S87, S197.
35. Li,D., Dragan,Y., Jordan,V.C., Wang,M. and Pitot,H.C. (1997) Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Cancer Res., 57, 1438-1441.
36. Busch,H. (1997) Adducts and tamoxifen. Semin Oncol., 24 (Suppl. 1), S1-S98, S1104.
37. Tannenbaum,S.R. (1997) Comparative metabolism of tamoxifen and DNA adduct formation and in vitro studies on genotoxicity. Semin Oncol., 24 (Suppl. 1), S1-S81, S16.
38. Cai,Q. and Wei,H. (1995) In vivo formation of DNA adducts in mouse skin by tamoxifen. Cancer Lett., 92, 187-192.
39. Ye,Q. and Bodell,W.J. (1996) Production of 8-hydroxy-2′-deoxyguanosine in DNA by microsomal actiovation of tamoxifen and 4-hydroxytamoxifen. Carcinogenesis, 17, 1747-1750.